$ACMR

Wang David H sold $10.6M of ACMR

Wang David H (See Remarks) sold 140,000 shares of ACM Research, Inc. (ACMR) at an average of $75.93 ($73.80–$78.57, $10.63M total) across 9 trades over 2026-09-08 to 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Sep 10, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Bearish
medium confidence
Mentioned
$ACMR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRBearishLow
01

Why it matters

The disclosed sale reduces insider ownership and may influence short‑term trading sentiment.

02

Market read

Insider sell of over $10 M is noteworthy for traders monitoring ACMR's stock.

03

What to watch

Pre‑arranged 10b5‑1 plan could be routine liquidity management, not a negative signal.

Relevance 6/10Novelty 8/10Timing: filing disclosed after market close on 2026‑09‑10

Background

SEC Form 4 filing reports insider transaction for ACM Research, Inc.

Company-level read

Ticker impact

$ACMRBearishMedium confidence
Context

Officer/director sold $10.6M of shares via 10b5‑1 plan, reducing holdings to 802,708.

Expected impact

Potential modest price decline in near term.

Evidence & confidence

Large insider sale by a 10% owner often precedes negative sentiment; market may interpret as lack of confidence.

Market effects

Minimal impact on semiconductor equipment sector; isolated to ACMR.

Negligible effect on broader US market.

Limited to investors tracking insider activity.

Counterpoint

Insider may be diversifying portfolio; sale does not necessarily reflect company fundamentals.

Key entities

  • Wang David H

    10% owner of ACMR who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.